Cited by 818Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersPolyomavirus and related diseases

The DOI matches its Crossref record; 96 of the 98 references it cites were found in a registry or an index.

Primary-progressive multiple sclerosis

Miller, David H, Leary, Siobhan M·2007·The Lancet Neurology

Open this paper in CoChat — free account

Abstract

About 10-15% of patients with multiple sclerosis (MS) present with gradually increasing neurological disability, a disorder known as primary-progressive multiple sclerosis (PPMS). Compared with relapse-onset multiple sclerosis, people with PPMS are older at onset and a higher proportion are men. Inflammatory white-matter lesions are less evident but diffuse axonal loss and microglial activation are seen in healthy-looking white matter, in addition to cortical demyelination, and quantitative MRI shows atrophy and intrinsic abnormalities in the grey matter and the white matter. Spinal cord atrophy corresponds to the usual clinical presentation of progressive spastic paraplegia. Although neuroaxonal degeneration seems to underlie PPMS, the pathogenesis and the extent to which immune-mediated mechanisms operate is unclear. MRI of the brain and spinal cord, and examination of the CSF, are important investigations for diagnosis; conventional immunomodulatory therapies, such as interferon beta and glatiramer acetate, are ineffective. Future research should focus on the clarification of the mechanisms of axonal loss, improvements to the design of clinical trials, and the development of effective neuroprotective treatments.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(07)70243-0

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Defining the clinical course of multiple sclerosis
LUBLIN, F. D., & Reingold, S. C. (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,762
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,328
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
Cutter, G. (1999) · Brain · doi:10.1093/brain/122.5.871 · Cited by 1,191
The natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P., Koopman, W. J., Hader, W. J., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,169
The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure
Hobart, J. (2001) · Brain · doi:10.1093/brain/124.5.962 · Cited by 1,144
Natural history of multiple sclerosis: a unifying concept
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awl007 · Cited by 901
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898

Show all 98 references

Research works printed but not linked: 1

Kita, 2004, A phase II trial of mitoxantrone in patients with primary progressive multiple sclerosis, Neurology, 62, A99

Sorted by citations

Items 401–500 of 814

Prognostic value of neurofilament light chain protein and glial fibrillary acidic protein in multiple sclerosis subtypes and disease activity patterns: a systematic review and meta-analysis
Yang, C., Jiang, C., Wang, Y., Hu, Y., Li, Y., Zhou, P., & Wang, Y.-H. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09187-x · Cited by 1
Central pain symptoms in multiple sclerosis
Jarvis, S. E., & Kerr, B. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.014 · Cited by 1
Comment je traite une sclérose en plaques ?
Clanet, M. (2010) · Pratique Neurologique - FMC · doi:10.1016/s1878-7762(10)70026-1 · Cited by 1
Grijzestofpathologie bij multiple sclerose: histopathologische, moleculair biologische en MRI-studies
Kooi, E. (2013) · Neuropraxis · doi:10.1007/s12474-013-0019-7 · Cited by 1
Association of CD24V/V genotype with susceptibility and progression of multiple sclerosis in Iranian population
Ronaghi, M., Vallian, S., & Etemadifar, M. (2008) · Iranian Journal of Biotechnology · Cited by 1
Clinical Symptoms and Therapies for Multiple Sclerosis
Arya, A., Kumar, S., & Sindhu, R. K. (2015) · Journal of Pharmaceutical Technology Research and Management · doi:10.15415/jptrm.2015.31003 · Cited by 1
Progressive Weakness, Cognitive Dysfunction and Seizures
Sim, L. E., & Tan, K. (2016) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v45n7p330 · Cited by 1
Signes et symptômes de la sclérose en plaques
Brochet, B., Lebrun‐Frénay, C., Seze, J. D., Zéphir, H., Allart, E., Audoin, B., Ayrignac, X., Bensa, C., Blanchard-Dauphin, A., Brassat, D., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-2-294-75020-5.00001-6 · Cited by 2
Multiple sclerosis: treatment, monitoring, activity and disability
Pavelek, Z., & Vališ, M. (2018) · Neurologie pro praxi · doi:10.36290/neu.2018.104 · Cited by 1
Overlap autoimmune syndrome: primary progressive multiple sclerosis, primary biliary cirrhosis, Raynaud phenomena with digital necrosis
Bistriceanu, C. E., Danciu, F. A., & Cuciureanu, D. I. (2021) · Acta Neurologica Belgica · doi:10.1007/s13760-021-01833-9 · Cited by 1
Motor Neuron Disease: To Identify the Mimics and Chameleons at the Early Stage
Ekladious, A., & Jiang, B. (2022) · International Journal of Biomedical Research & Practice · doi:10.33425/2769-6294.1017 · Cited by 1
A case of primary progressive multiple sclerosis with improvement in cognitive impairment by anti-CD20 monoclonal antibody therapy
Onoue, H., Kato, Y., Ishido, H., Ogawa, T., Akaiwa, Y., & Miyamoto, T. (2023) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001779 · Cited by 1
Survival and Its Correlates in Multiple Sclerosis Patients under a Universal Health Insurance Program in Taiwan: An 18-Year Nationwide Cohort Study
Liao, C.-M., Chen, C., Kung, P., Kuo, W.-Y., Chuang, H.-C., & Tsai, W. (2023) · Healthcare · doi:10.3390/healthcare11111551 · Cited by 1
Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis—Results from the MAGNON project
Leussink, V. I., Jankovic, M., Groth, M., Schuh, K., Sauerbeck, I. S., & Hoffmann, O. M. (2024) · Brain and Behavior · doi:10.1002/brb3.3548 · Cited by 1
Multiple sclerosis
Saab, G., & Khoury, S. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00061-8 · Cited by 1
Urology and nephrology
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.205.c28 · Cited by 1
Applications of MR fiber tractography imaging in multiple scleros
El-Sourgy, L., Ahmad, N., Elrakhawy, M. M., Gomaa, M., & Hegazi, M. A. (2015) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1016/j.ejrnm.2015.01.007 · Cited by 2
Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases
Keegan, B. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107281943 · Cited by 2
Structural and Functional Neuroimaging in Multiple Sclerosis: From Atrophy, Lesions to Global Network Disruption
Tewarie, P. K. B., Schoonheim, M. M., & Hillebrand, A. (2018) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-78926-2_8 · Cited by 1
Risk factors for infusion-related reactions following Ocrelizumab infusion in a community setting: Development of an electronic medical record-based explanatory model
O'Nell-Meyer, H., Wei, O. E., Ruiz, J. A., Wade, P. B., Neto, L. O., & Gromisch, E. S. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102700 · Cited by 1
Microglia and border-associated macrophages in the central nervous system
Zanluqui, N. G., Polonio, C. M., de Oliveira, M. G., de Oliveira, L. G., Faria, L. C., & Peron, J. P. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821385-8.00013-5 · Cited by 1
A bibliometric evaluation of the top 100 cited articles on ocrelizumab
Altunışık, E., Cengiz, E. K., & Keçeli, Y. K. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104856 · Cited by 1
Chapter 9. Informed consent
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.209.09inf · Cited by 1
Interferon-beta treatment in multiple sclerosis : Analysis of neutralizing antibodies
Sominanda, A. (2008) · Figshare · Cited by 1
Reconstituição imunológica após transplante autólogo de células-tronco hematopoéticas em pacientes com diabetes mellitus tipo 1 e esclerose múltipla
Arruda, L. C. M. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2013.tde-21102013-122404 · Cited by 1
Clinical Neurophysiology in multiple sclerosis – From diagnostic tool to biomarker
Fuhr, P., & Schindler, C. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.06.003 · Cited by 1
Mechanisms for Extracellular Matrix-Dependent Blood-Brain Barrier Dysfunction
Hoettles, B. A. (2021) · doi:10.18122/td/1903/boisestate · Cited by 1
Multiple Sclerosis: The Next 20 Years
Weiner, H. L. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-860-7_10 · Cited by 1
The Effects of Chronic Restraint Stress on Innate and Adaptive Immune Responses to Acute Theiler?s Murine Encephalomyelitis Virus Infection ? An Animal Model of Human Multiple Sclerosis
Steelman, A. J. (2008) · OakTrust (Texas A&M University Libraries)
Establishment and Applications of a Multiple Sclerosis Biobank Analysis of Biomarkers and Therapeutic Complications in MS
Iacobaeus, E. (2010) · Figshare
Euphoria in multiple sclerosis: an investigation of constructs and symptons
Duncan, A. L. (2014) · Open University of Cape Town (University of Cape Town)
Controversias en Neurología: Esclerosis Múltiple
Toro, J., Reyes, S., & Zamora, A. C. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Genetic analysis of chromosomal regions 2q33, 7q32 and 19q13 in multiple sclerosis susceptibility
Bonetti, A. (2009) · Työväentutkimus Vuosikirja
Mechanisms and Patterns of Axonal Loss in Multiple Sclerosis
Mayo, Z., & Jacob, A. (2012) · InTech eBooks · doi:10.5772/35703
Imaging Disease Progression
Chard, D., & Miller, D. H. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2395-8_6
Self-citation
Quantitative Magnetic Resonance Imaging of the Brain : Applications for Tissue Segmentation and Multiple Sclerosis
West, J. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-103043
New Hope for Multiple Sclerosis Patients
Lindsley, C. W. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400059g
Multiple sclerosis: offering care tailored to the person's needs
Nazarko, L. (2013) · British Journal of Healthcare Assistants · doi:10.12968/bjha.2013.7.12.594
Teaching case: A man with a progressive gait impairment and visual compromise
Toro, J., Burbano, L. E., Zamora, A. C., & Jones, E. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.02.001
Investigation of genetic factors in multiple sclerosis
Bomfim, I. L. (2009) · Figshare
Longterm prognosis of multiple sclerosis in untreated patients and in patients treated with first generation immunmodulators
Tedeholm, H. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Multiple Sclerosis as a Scientific Problem
Ebringer, A. (2014) · Springer eBooks · doi:10.1007/978-3-319-02735-7_1
The influence of common infections on clinical course and neurodegeneration in an animal model of multiple sclerosis
Kumar, P. (2015) · doi:10.53846/goediss-4967
Pseudotumor desmielinizante medular. Informe de autopsia
Alemán, I. G., Valdez, J. R., & Gutiérrez, S. V. (2013) · Acta Médica del Centro
Contribution of Micronutrients Intake to the Risk of Multiple Sclerosis: Is the Available Evidence Convincing?
Saneei, P., & Esmaillzadeh, A. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Innate immunity in progressive multiple sclerosis
Aeinehband, S. (2015) · Figshare
The Lived Experience of Mothering for Women with Multiple Sclerosis
Plumb-Parlevliet, A. M. (2015) · Australasian Journal of Paramedicine
CHRONIC CEREBRO SPINAL VENOUS INSUFFICIENCY (CCSVI): A NEW HYPOTHESIS FOR MULTIPLE SCLEROSIS L'INSUFFICIENZA VENOSA CRONICA CEREBRO SPINALE (CCSVI): UNA NUOVA IPOTESI PER LA SCLEROSI MULTIPLA
Mandolesi, S., Sio, S. D., Pastena, C. D., Scala, B., Loreti, B., Corbosiero, P., Sinibaldi, F., Sacco, C., Cappelli, L., Casale, T., et al. (2013)
Cumplimiento de los criterios clínicos, de laboratorio e imagenológicos para el diagnóstico de esclerosis múltiple : Instituto Nacional de Ciencias Neurológicas 2001-2010
Suárez, M., & Elsa, G. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The reproductive system
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.28the
The immune and lymphatic system
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.24the
Neurology
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.17neu
Chapter 22. Muscles and the motor system
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.202.22mus
The endocrine system
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.25the
The digestive dystem
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.26the
Chapter 4. Medical terminology
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.202.04med
Urology and nephrology
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.27uro
The respiratory system
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.19the
Emergency Departments or ERs
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.08eme
Chapter 5. Primary care physicians and General Practitioners
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.202.05pri
Hereditary and Acquired Cerebellar Ataxias
Koutsis, G., & Wood, N. W. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199609536.003.0027
Cardiology
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.18car
Validation of an Internet-based Approach to Cognitive Screening in Multiple Sclerosis
Akbar, N. (2011) · TSpace (University of Toronto)
Speech Language Therapy
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.14spe
Hematology
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.20hem
Hospitals
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.07hos
Pitfalls in correctly assessing the clinical course of MS
Keegan, B. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107281943.003
Chapter 10. Pre-operative and post-operative procedures
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.209.10pre
Intensive Care
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.11int
Orthopedics
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.21ort
Remyelination in the Central Nervous System
(1989) · KARGER eBooks · doi:10.1159/isbn.978-3-8055-8766-2
The sensory system
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.23the
Interpreting in healthcare settings
(2013) · John Benjamins Publishing Company eBooks · doi:10.1075/z.181.02int
Chapter 3. A word about culture
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.209.03the
Chapter 28. Urology and gynecology; the reproductive systems
Crezee, I. H. M., Mikkelson, H. M., & Monzon-Storey, L. (2015) · John Benjamins Publishing Company eBooks · doi:10.1075/z.193.c28
Chapter 28. Urology and gynecology
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.202.28uro
Chapter 4. Healthcare Insurance
Crezee, I. H. M., Mikkelson, H. M., & Monzon-Storey, L. (2015) · John Benjamins Publishing Company eBooks · doi:10.1075/z.193.04hea
Chapter 5. Primary care physicians
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.209.05pri
Chapter 27. Urology and nephrology
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.202.27uro
Chapter 6. Specialty clinics and Outpatient Clinics
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.202.06spe
Chapter 6. Specialty clinics
(2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.209.06spe
Chapter 8. Characteristics of the Japanese healthcare system
Asano, T., & Murai, H. (2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.205.08cha
Immunomodulatory Therapy for Multiple Sclerosis
Cortese, I. C. M., & Nath, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_43
Chapter 3. The culture of Japanese medicine
Morrone, M. H. (2016) · John Benjamins Publishing Company eBooks · doi:10.1075/z.205.03the
Kognitiivinen uupumus ja kieli MS-taudissa. Semispontaanien narratiivien määrällinen ja laadullinen analyysi
Heikkola, L. M. (2017) · Virittäjä · doi:10.23982/vir.63151
Pregnancy Considerations and Pregnancy Outcomes in Women with MS
D'hooghe, M. B., Reynders, T., & Keyser, J. D. (2017) · Springer eBooks · doi:10.1007/978-3-7091-4858-7_3
Avaliação da capacidade reguladora de células tronco mesenquimais endometriais no modelo de encefalomielite experimental automimune.
Polonio, C. M. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2017.tde-16112017-103200
Computational approaches to identify novel drug-like immunomodulators against multiple sclerosis
Syed, A. H. (2019) · International Journal of ADVANCED AND APPLIED SCIENCES · doi:10.21833/ijaas.2019.04.004
A Comparative Study of Emotional Regulation, Quality of Life, and Resilience in Patients with Multiple Sclerosis and Healthy People
Chari, M., & Shirazi, M. (2019) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc.85910
Immunoadsorption Techniques and Its Current Role in the Intensive Care Unit
Hamilton, P., Harris, R., & Mitra, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84890 · Cited by 6
Regional astrocyte interferon-γ signaling regulates immunoproteasome-mediated protection during chronic autoimmunityPreprint
Smith, B. C., Sinyuk, M., Jenkins, J. E., Psenicka, M. W., & Williams, J. L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.23.887455
Urology and nephrology
(2022) · John Benjamins Publishing Company eBooks · doi:10.1075/z.241.c27
Propriedades psicométricas da Escala de Graus de Doença Determinados pelo Paciente com Esclerose múltipla
Quaresma, L. M., de Lima, M. S. N., & Paz, C. C. D. S. C. (2020) · Revista Neurociências · doi:10.34024/rnc.2020.v28.9708
Análise crítica da evolução da capacidade funcional, por meio do EDSS, em pacientes com esclerose múltipla submetidos ao transplante de medula óssea
Fusco, T. (2020) · doi:10.11606/t.17.2020.tde-13022020-105054
Imaging Disease Progression
Chard, D., & Ciccarelli, O. (2017) · Springer eBooks · doi:10.1007/978-3-319-65921-3_5
Pirminė progresuojanti išsėtinė sklerozė: nuo patogenezės iki gydymo naujovių. Literatūros apžvalga
Juknelytė, A., Vaičekauskytė, Ž., Mickevičienė, D., & Balnytė, R. (2020) · Neurologijos seminarai · doi:10.29014/10.29014/ns.2020.04
Longitudinal modeling of MS patient trajectories improves predictions of disability progressionPreprint
Brouwer, E. D., Becker, T., Moreau, Y., Havrdová, E., Trojano, M., Eichau, S., Özakbaş, S., ONOFRJ, M. C., Grammond, P., Kühle, J., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2011.04749
Commentary: The Impact of Regional Astrocyte Interferon- Signaling During Chronic Autoimmunity: A Novel Role for the Immunoproteasome
Smith, B. C., & Williams, J. L. (2021) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2021/1.1204
The effect of dimethyl fumarate on phenotype and function of B lymphocytes in MS patients
Traub, J. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8525
Attenuating the Progression and Preventing the Onset of Experimental Autoimmune Encephalomyelitis by Transient pH DisturbancesPreprint
Zeng, W. (2021) · doi:10.31219/osf.io/st2a3

Authors: Miller, D. H., & Leary, S. M.
Affiliations: UCL Queen Square Institute of Neurology (GB)
University College Hospital (GB)
ORCID: Leary, Siobhan M
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2007-10
Volume: 6
Issue: 10
Pages: 903-912
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(07)70243-0
OpenAlex: W1990040006
Cited by: 818
References: 98
Citations by year: 2026: 18 · 2025: 23 · 2024: 30 · 2023: 32 · 2022: 74 · 2021: 74 · 2020: 29 · 2019: 26 · 2018: 32 · 2017: 33 · 2016: 161 · 2015: 66 · 2014: 33 · 2013: 71 · 2012: 19
FWCI: 2.78
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Multiple Sclerosis Society
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
Keywords: primary progressive multiple sclerosis, axonal loss, neuroaxonal degeneration, microglial activation, cortical demyelination, spinal cord atrophy, quantitative MRI, cerebrospinal fluid biomarkers, interferon-beta, glatiramer acetate, neuroprotection, pathogenesis
MeSH terms: Brain, Diagnosis, Differential, Humans, Magnetic Resonance Imaging, Multiple Sclerosis, Chronic Progressive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Primary-progressive multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks